Measurement of ethyl methanesulfonate in human plasma and breast milk samples using high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 52, Issue 2, 2010, Pages 260-264

  Montesano, M Angela ^a   Whitehead, Ralph D ^a   Jayatilaka, Nayana K ^a   Kuklenyik, Peter ^a   Davis, Mark D ^a   Needham, Larry L ^a   Barr, Dana Boyd ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Electrospray ionization; EMS; Ethyl methanesulfonate; HPLC; Mass spectrometry

Indexed keywords

ACETIC ACID ETHYL ESTER; MESYLIC ACID ETHYL ESTER; NELFINAVIR;

ACCURACY; ARTICLE; BREAST MILK; CONCENTRATION PROCESS; CONTROLLED STUDY; DRUG CONTAMINATION; DRUG DISTRIBUTION; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PLASMA; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; SOLVENT EXTRACTION; TANDEM MASS SPECTROMETRY;

ATMOSPHERIC PRESSURE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHYL METHANESULFONATE; FEMALE; HUMANS; LIMIT OF DETECTION; MILK, HUMAN; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; MUTAGENS; PREGNANCY; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 77349103617     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.12.030     Document Type: Article

References (14)

1. Ramjit H.G. Gas chromatographic/mass sectrometric analysis of methyl methanosulphonate and ethyl methanosulphonate in the bismesylate salt of DPI 201-106, a positive inotropic agent for the treatment of heart failure. J. Mass Spectrom. 1996, 31:867-872.
2. Li W. Trace analysis of residual methyl methanesulfonate, ethyl methanesulfonate and isopropyl methanesulfonate in pharmaceuticals by capillary gas chromatography with flame ionization detection. J. Chromatogr. A 2004, 1046:297-301.
3. Snodin D.J. Residues of genotoxic alkyl mesylates in mesylate salt drug substances: real or imaginary problems?. Regul. Toxicol. Pharm. 2006, 45:79-90.
4. Elder D.P., Snodin D.J. Drug substances presented as sulfonic acid salts: overview of utility, safety and regulation. J. Pharm. Pharmacol. 2009, 61:269-278.
5. Jacq K., Delaney E., Teasdale A., Eyley S., Taylor-Worth K., Lipczynski A., Reif V.D., Elder D.P., Facchine K.L., Golec S., Oestrich R.S., Sandra P., David F. Development and validation of an automated static headspace gas chromatography-mass spectrometry (SHS-GC-MS) method for monitoring the formation of ethyl methane sulfonate from ethanol and methane sulfonic acid. J. Pharm. Biomed. Anal. 2008, 48:1339-1344.
6. Müller L., Gocke E., Lavé T., Pfister T. Ethyl Methanesulfonate toxicity in Viracept-a comprehensive human risk assessment based on threshold data for genotoxicity. Toxicol. Lett. 2009, Epub ahead of print.
7. Gocke E., Müller L., Pfister T. EMS in Viracept-initial ('traditional') assessment of risk to patients based on linear dose response relations. Toxicol. Lett. 2009, Epub ahead of print.
8. Sega G.A. A review of the genetic effects of ethyl methanesulfonate. Mutat. Res. 1984, 134:113-142.
9. Platzek T., Bochert G., Meister R. Embryotoxicity induced by alkylating agents. Teratogen. Carcinogen. Mutagen. 1995, 15:81-92.
10. Bökel C. EMS screens: from mutagenesis to screening and mapping. Method Mol. Biol. 2008, 420:119-138.
11. Gocke E., Bürgin H., Müller L., Pfister T. Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate. Toxicol. Lett. 2009, Epub ahead of print.
12. Ramakrishna K., Raman N.V.V.S.S., Narayana Raob K.M.V., Prasad A.V.S.S., Reddy K.S. Development and validation of GC-MS method for the determination of methyl methanesulfonate and ethyl methanesulfonate in imatinib mesylate. J. Pharm. Biomed. Anal. 2008, 46:780-783.
13. ® 250mg tablets by gas chromatography-mass spectrometry. Pharm. Sci. Notes, z1 2008, 17-20.
14. Taylor J.K. Quality Assurance of Chemical Measurements 1987, Lewis Publishers, Boca Raton.